Iveric Bio Announces the Addition of Pravin U. Dugel, MD, to its Board of Directors

Author's Avatar
Jan 03, 2023

IVERIC+bio%2C+Inc. (Nasdaq: ISEE) announced today the election of Pravin U. Dugel, MD, President of Iveric Bio, to its Board of Directors, effective as of January 1, 2023. Dr. Dugel has been instrumental in helping to shape the Company’s business strategy and in overseeing the development and regulatory submission process for avacincaptad pegol (ACP, also known as Zimura®) since he joined Iveric Bio in 2020.